Why is Neuland Labs. falling/rising?

As of 29-Aug, Neuland Laboratories Ltd is experiencing a price increase, currently at Rs 13,456.75, which reflects a rise of Rs 191.9 or 1.45%. The stock has shown a positive performance today, outperforming its sector by 1.42% and has gained consecutively over the last two days, with a total return of 2.47% during this period. Despite this recent uptick, the stock has faced challenges, as indicated by its performance over the past week and month, where it has declined by 2.73% and 2.87%, respectively. The company has a strong ability to service debt, evidenced by a low Debt to EBITDA ratio of 0.57 times, and high institutional holdings at 33.66%, which may provide some support for the stock. However, the company has reported negative results over the last four consecutive quarters, including a significant drop in net sales and profits, which raises concerns about its long-term growth potential.
In the broader market context, Neuland Laboratories Ltd's short-term performance has been relatively better compared to the benchmark Sensex, which has declined by 1.84% over the past week. While the stock has generated a return of 9.23% over the last year, it is important to note that its profits have fallen by 58.9%, indicating a disconnect between stock performance and underlying financial health. The stock's valuation appears expensive with a Price to Book Value of 11.3, suggesting that it is trading at a premium compared to its peers. This combination of recent gains, strong institutional backing, and ongoing concerns about financial performance creates a complex picture for investors considering the stock's future trajectory.